Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02425566
PHASE1

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Sponsor: Vanderbilt University

View on ClinicalTrials.gov

Summary

The purpose of this study is to better understand the role of the abdominal veins (splanchnic capacitance) and the sympathetic nervous system in human hypertension. The investigators will test the hypothesis that constriction of abdominal veins due to sympathetic activation contributes to human hypertension. Splanchnic capacitance will be assessed in normotensive and hypertensive subjects at baseline and during acute blockade of the autonomic nervous system.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2015-04

Completion Date

2026-08

Last Updated

2025-08-21

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Trimethaphan

Trimethaphan is a Nn-nicotinic receptor antagonist that blocks sympathetic and parasympathetic transmission at the level of the autonomic ganglia. It will be administered as an acute intravenous infusion with doses ranging from 0.5 to 5.0 mg/min.

DRUG

Nitroglycerin

Sublingual nitroglycerin (0.3-0.6 mg) will be given after baseline measurements.

Locations (1)

Autonomic Dysfunction Center

Nashville, Tennessee, United States